Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.

World J Hepatol · 2020 · PMC7522558 · PMID 33033572

Europe PMC DOI

hedged sentence

1.0000

closest p · 20.0× alpha

1.0000

boldest claim

The sentences

difference was apparentP = 1.000not close (p > 0.1)

No significant difference was apparent between groups ( P = 1.000).

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.